Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Aron Gyorgypal"'
Autor:
Erica J. Fratz-Berilla, Casey Kohnhorst, Nicholas Trunfio, Xin Bush, Aron Gyorgypal, Cyrus Agarabi
Publikováno v:
Heliyon, Vol 10, Iss 3, Pp e25512- (2024)
Culture pH is a critical process parameter during CHO cell bioreactor operations that is key for proper cell growth, protein production, and maintaining the critical quality attributes of a monoclonal antibody drug substance. The traditional means of
Externí odkaz:
https://doaj.org/article/acbdf2b755b546b48268b58abee6b86f
Publikováno v:
Journal of Pharmaceutical Sciences. 112:1485-1491
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::26aba14287ac6ee3ea1f5e0f85e4e16c
https://doi.org/10.1016/j.xphs.2023.01.012
https://doi.org/10.1016/j.xphs.2023.01.012
Autor:
Aron Gyorgypal, Shishir P.S. Chundawat
Publikováno v:
Analytical Chemistry. 94:6986-6995
The biopharmaceutical industry is transitioning toward the adoption of continuous biomanufacturing practices that are often more flexible and efficient than traditional batch processes. Federal regulatory agencies are further urging the use of advanc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35c85b34c5fd4d875b57283ab46ab104
https://doi.org/10.1021/acs.analchem.1c05396
https://doi.org/10.1021/acs.analchem.1c05396
Publikováno v:
Reaction Chemistry & Engineering.
With the transition toward continuous bioprocessing, Process Analytical Technology (PAT) is becoming necessary for rapid and reliable in-process monitoring during biotherapeutics manufacturing. Bioprocess 4.0 is looking to build end-to-end bioprocess
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d29c0fd503b783c8f5b59f072df2cfc5
https://doi.org/10.1039/d2re00568a
https://doi.org/10.1039/d2re00568a
With the transition toward continuous bioprocessing, process analytical technology (PAT) is becoming necessary for rapid and reliable in-process monitoring during biotherapeutics manufacturing. Bioprocess 4.0 is looking to build an end-to-end bioproc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::79249e43779844510c9bc2df3f1785fc
https://doi.org/10.1101/2022.12.22.521623
https://doi.org/10.1101/2022.12.22.521623
Post-translational modification such as N-Glycosylation on biologics during the production of monoclonal antibody (mAb) based therapeutics is a critical quality attribute that dictates safety and efficacy. Variability is introduced in the cell cultur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::184d8a1c73cf37fe4618a69f90517a14
https://doi.org/10.26434/chemrxiv-2022-sdq2g
https://doi.org/10.26434/chemrxiv-2022-sdq2g